出血时间检测与酒精使用障碍患者创伤性颅脑损伤相关特征的关系
研究纳入52例伴酒精使用障碍(AUD)的中重度创伤性颅脑损伤(TBI)患者,以121例无AUD的TBI患者为对照,入院时行IVY出血时间检测。AUD组出血时间延长者占69.2%,出血时间≥900 s者血肿更大、更常需颅内压监测和机械通气,但6个月预后在出血时间分组间无差异。
要点
- 伴AUD的TBI患者中出血时间延长者占69.2%,血小板计数低者占44.2%。
- 出血时间≥900 s者血肿更大,更常需颅内压监测和机械通气(p<0.05)。
- 出血时间分组间6个月预后无差异(p>0.05),该检测特异性低。
核心结论
- 伴与不伴AUD的TBI患者出血时间存在差异,且血小板计数正常者也可能出现出血时间延长,但出血时间检测作为初级止血和血小板功能标志物特异性低,可作为伴AUD的TBI患者整体状态评估的补充,应仅结合出血史和其他血液学指标谨慎评估后使用。
研究设计与样本
- 研究纳入52例有AUD证据的中重度TBI患者,入院期间在神经重症监护下按IVY法行出血时间检测,并以121例无AUD病史的TBI患者作为对照。
主要发现
- 伴AUD的TBI患者中血小板计数低者占44.2%,出血时间延长者占69.2%,出血时间值与血小板计数呈负相关(p<0.05)。
- 出血时间≥900 s的TBI患者较出血时间<900 s者血肿体积显著增大,更常需颅内压监测和机械通气(p<0.05)。
- 血小板计数低的患者中88%存在出血时间延长。
- 出血时间分组间6个月预后无差异(p>0.05)。
- 无AUD证据的TBI患者出血时间值更低、血小板计数更高(p<0.05)。
关键数值与推荐
- 出血时间正常定义为≤600 s,延长定义为>600 s,显著延长定义为≥900 s。
- 正常血小板计数定义为>150,000/μL。
临床怎么用
- 作者认为出血时间检测可作为伴AUD的TBI患者整体状态评估的补充,但应仅结合患者出血史和其他血液学指标的仔细评估使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND-AIM: Traumatic brain injury (TBI) and alcohol use disorder (AUD) can occur concomitantly and be associated with coagulopathy that influences TBI outcome. The use of bleeding time tests in TBI management is controversial. We hypothesized that in TBI patients with AUD, a prolonged bleeding time is associated with more severe injury and poor outcome. MATERIAL AND METHODS: Moderate and severe TBI patients with evidence of AUD were examined with bleeding time according to IVY bleeding time on admission during neurointensive care. Baseline clinical and radiological characteristics were recorded. A standardized IVY bleeding time test was determined by staff trained in the procedure. Bleeding time test results were divided into normal (≤ 600 s), prolonged (> 600 s), and markedly prolonged (≥ 900 s). Normal platelet count (PLT) was defined as > 150,000/μL. This cohort was compared with another group of TBI patients without evidence of AUD. RESULTS: Fifty-two patients with TBI and AUD were identified, and 121 TBI patients without any history of AUD were used as controls. PLT was low in 44.2% and bleeding time was prolonged in 69.2% of patients. Bleeding time values negatively correlated with PLT (p < 0.05). TBI patients with markedly prolonged values (≥ 900 s) had significantly increased hematoma size, and more frequently required intracranial pressure measurement and mechanical ventilation compared with those with bleeding times < 900 s (p < 0.05). Most patients (88%) with low platelet count had prolonged bleeding time. No difference in 6-month outcome between the bleeding time groups was observed (p > 0.05). Subjects with TBI and no evidence for AUD had lower bleeding time values and higher platelet count compared with those with TBI and history of AUD (p < 0.05). CONCLUSIONS: Although differences in the bleeding time values between TBI cohorts exist and prolonged values may be seen even in patients with normal platelet count, the bleeding test is a marker of primary hemostasis and platelet function with low specificity. However, it may provide an additional assessment in the interpretation of the overall status of TBI patients with AUD. Therefore, the bleeding time test should only be used in combination with the patient's bleeding history and careful assessment of other hematologic parameters.
引用
- Tsitsopoulos PP, Marklund N, Rostami E, et al. Association of the bleeding time test with aspects of traumatic brain injury in patients with alcohol use disorder. Acta Neurochir (Wien). 2020. PMID: 32424564. doi:10.1007/s00701-020-04373-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。